Stocks
Dicerna Pharmaceuticals (DRNA) R&D US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 41.7 | 37.0 | 45.7 | 109.3 | 205.4 | 227.4 | |||
| Changes by years, y/y, % | -5% | -11% | +24% | +139% | +88% | +36.1% | |||
Dicerna Pharmaceuticals. R&D, bln rub
Dicerna Pharmaceuticals. R&D, changes, %
Dicerna Pharmaceuticals. R&D, sum by quarters, bln rub
Dicerna Pharmaceuticals (DRNA) R&D US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| R&D, bln rub | 54.8 | 54.0 | 56.0 | 56.1 | 61.2 | 227.4 | ||
| Changes by years, y/y, % | +82% | +55% | +30% | +5% | +12% | |||
| Changes by quarters, q/q, % | +3% | -1% | +4% | +0% | +9% | |||
